INTRODUCTIONMelasma is a pigmentary disorder affecting over 5 million people in the United States.1 The term "melasma" is derived from the Greek root word "melas," which means black, referring to…
Read More
INTRODUCTIONImmunosuppressive and immunomodulatory medications are widely utilized in dermatology to treat chronic inflammatory skin conditions. However, their use in patients with active or prior malignancy remains an area of uncertainty.…
Read More
INTRODUCTIONPsoriatic arthritis (PsA) is a debilitating inflammatory arthropathy and a major long-term complication of psoriasis, affecting up to 30% of patients.1 Although the mechanistic link between cutaneous psoriasis and PsA…
Read More
INTRODUCTIONCentral Centrifugal Cicatricial Alopecia (CCCA) is characterized by progressive scarring and hair loss in the vertex or crown of the scalp and spreads centrifugally. CCCA is associated with inflammation and…
Read More
To the Editor, Hidradenitis suppurativa (HS) is a chronic inflammatory skin condition characterized by painful nodules, abscesses, and sinus tracts.1 Though HS primarily affects intertriginous areas, it may involve the…
Read More
INTRODUCTIONBis-ethylhexyloxyphenol methoxyphenyl triazine (BEMT) is a UVA/UVB sun filter that has been approved for use in the European Union since 2000. In June 2026, the FDA approved BEMT as a…
Read More
INTRODUCTIONLichen planus pigmentosus (LPP) is an acquired dermal melanosis that typically affects photo-exposed and flexural surfaces. Q-switched neodymium: yttrium aluminum garnet (QS Nd:YAG) lasers target dermal melanosis and have shown…
Read More
INTRODUCTIONVitiligo can significantly impact the quality of life of affected individuals and their family members. Support groups provide numerous benefits, including allowing individuals to give and receive emotional and practical…
Read More
INTRODUCTIONNonmelanoma skin cancer (NMSC) is the most common malignancy in the United States, and a growing public health concern.1 While a variety of prevention strategies exist for high-risk groups such…
Read More
INTRODUCTIONNeurodegenerative disorders are a prevalent cause of morbidity, often carrying substantial physical and psychosocial burden. Alzheimer's disease (AD) and Parkinson's disease (PD) are the most common neurodegenerative disorders, and both…
Read More
INTRODUCTIONTildrakizumab is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that selectively binds the p19 subunit of interleukin-23 (IL-23), a key cytokine in the pathogenesis of psoriasis.1-4 In the pivotal phase…
Read More
In this article:Tildrakizumab for Real-World Psoriasis Care: Clinical Lessons From Medically Complex and Underserved Patient Populations Tildrakizumab is a humanized immunoglobulin G1 (IgG1) monoclonal antibody that selectively binds the p19…
Read More
